Ono Pharmaceutical

02.05.2024 • News

Ono to Acquire Deciphera for $2.4 Billion

Japan’s Ono Pharmaceutical agreed to acquire US cancer-therapy company Deciphera Pharmaceuticals for approximately $2.4 billion. Deciphera focuses on innovative cancer therapeutics, and specializes in kinase biology.

24.01.2017 • News

Merck Settles Keytruda Patent Disputes

04.10.2011 • News

Merck, Ono To Jointly Develop Oral Multiple Sclerosis Drug, Cancer Immunotherapy

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports

Virtual Event

DIGITALIZATION IN THE CHEMICAL INDUSTRY

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Ono Pharmaceutical

Ono to Acquire Deciphera for $2.4 Billion

Merck Settles Keytruda Patent Disputes

Merck, Ono To Jointly Develop Oral Multiple Sclerosis Drug, Cancer Immunotherapy

Top-Feature

Digitalization in the Chemical Industry

Fostering Innovation and Collaboration

Maximize the Potential of Spent Hydroprocessing Catalysts

Transport Logistic: Ecocool Presents Packaging Solutions for Pharmaceutical Transports

Virtual Event

DIGITALIZATION IN THE CHEMICAL INDUSTRY

Newsletter & e-edition